1H-MRS at 4 Tesla in minimally treated early schizophrenia

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

Simpson, G. M., B., M., B., G., Angus, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,265 · see citing works

A Rating Scale for Drug-Induced Akathisia

Barnes, T. R. E. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,179 · see citing works

ECDEU Assessment Manual: (591322011-001)

Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896 · see citing works

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works

Glutamate receptor dysfunction and schizophrenia

Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · see citing works

Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia

Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · see citing works

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

Sugahara, T., Korogi, Y., Kochi, M., Ikushima, I., Shigematu, Y., Hirai, T., Okuda, T., Liang, L., Ge, Y., Komohara, Y., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199901)9:1 · Cited by 1,151 · see citing works

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging

Magistretti, P. J., & Pellerin, L. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0471 · Cited by 750 · see citing works

Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water

Ernst, T., Kreis, R., & Ross, B. D. (1993) · Journal of Magnetic Resonance Series B · doi:10.1006/jmrb.1993.1055 · Cited by 508 · see citing works

Glutamate and Glutamine Measured With 4.0 T Proton MRS in Never-Treated Patients With Schizophrenia and Healthy Volunteers

Théberge, J., Bartha, R., Drost, D. J., Menon, R. S., MALLA, A. K., Takhar, J., Neufeld, R. W. J., Rogers, J. S., Pavlosky, W. F., Schaefer, B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1944 · Cited by 398 · see citing works

Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study

Rowland, L. M., Bustillo, J. R., Mullins, P. G., Jung, R. E., Lenroot, R., Landgraf, E., Barrow, R., Yeo, R., Lauriello, J., & Brooks, W. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.394 · Cited by 304 · see citing works

Glutamate and Glutamine in the Anterior Cingulate and Thalamus of Medicated Patients With Chronic Schizophrenia and Healthy Comparison Subjects Measured With 4.0-T Proton MRS

Théberge, J., Al-Semaan, Y. M., Williamson, P., Menon, R. S., Neufeld, R. W. J., Rajakumar, N., Schaefer, B., Densmore, M., & Drost, D. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2231 · Cited by 269 · see citing works

NMDA receptor regulation of memory and behavior in humans

Newcomer, J. W., & Krystal, J. (2001) · Hippocampus · doi:10.1002/hipo.1069 · Cited by 258 · see citing works

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

Steen, R. G., Hamer, R. M., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300850 · Cited by 254 · see citing works

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?

Farber, N. B., Wozniak, D. F., Price, M. T., Labruyere, J., Huss, J. M., Peter, H. S., & Olney, J. W. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00046-1 · Cited by 219 · see citing works

Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

Théberge, J., Williamson, K. E., Aoyama, N., Drost, D. J., Manchanda, R., Malla, A. K., Northcott, S., Menon, R. S., Neufeld, R. W. J., Rajakumar, N., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.033670 · Cited by 185 · see citing works

Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat

López-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301356 · Cited by 183 · see citing works

Increased Prefrontal and Hippocampal Glutamate Concentration in Schizophrenia: Evidence from a Magnetic Resonance Spectroscopy Study

van Elst, L. T., Valerius, G., Büchert, M., Thiel, T., Rüsch, N., Bubl, E., Hennig, J., Ebert, D., & Olbrich, H. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.041 · Cited by 164 · see citing works

3-T Proton MRS Investigation of Glutamate and Glutamine in Adolescents at High Genetic Risk for Schizophrenia

Tibbo, P. G., Hanstock, C. C., Valiakalayil, A., & Allen, P. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1116 · Cited by 152 · see citing works

Prospective multiaxial motion correction for fMRI

Ward, H. A., Riederer, S. J., Grimm, R. C., Ehman, R. L., Felmlee, J. P., & Jack, C. R. (2000) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(200003)43:3 · Cited by 132 · see citing works

Increased expression of the astrocytic glutamate transporter GLT‐1 in the prefrontal cortex of schizophrenics

Matute, C., Melone, M., Vallejo‐Illarramendi, A., & Conti, F. (2005) · Glia · doi:10.1002/glia.20119 · Cited by 129 · see citing works

Proton Magnetic Resonance Spectroscopic Imaging of Cortical Gray and White Matter in Schizophrenia

Lim, K. O., Elfar Adalsteinsson, A., Spielman, D. M., Sullivan, E. V., Rosenbloom, M. J., & Pfefferbaum, A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.346 · Cited by 122 · see citing works

Multi-component apparent diffusion coefficients in human brain: Relationship to spin-lattice relaxation

Mulkern, R. V., Zengingönül, H. P., Robertson, R. L., Bogner, P., Zou, K. H., Guðbjartsson, H., Guttmann, C. R. G., Holtzman, D. H., Kyriakos, W. E., Jolesz, F. A., et al. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200008)44:2 · Cited by 109 · see citing works

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients

Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L., & Iyo, M. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-6 · Cited by 106 · see citing works

Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial Dysfunction

Chang, L., Friedman, J. I., Ernst, T., Zhong, K., Tsopelas, N. D., & Davis, K. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.025 · Cited by 101 · see citing works

Implications for Altered Glutamate and GABA Metabolism in the Dorsolateral Prefrontal Cortex of Aged Schizophrenic Patients

Gluck, M. R., Thomas, R. G., Davis, K. L., & Haroutunian, V. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1165 · Cited by 98 · see citing works

Observation of Metabolic Changes in Chronic Schizophrenia After Neuroleptic Treatment by In Vivo Hydrogen Magnetic Resonance Spectroscopy

Choe, B., Suh, T. S., Shinn, K.-S., Lee, C., Lee, C., & Paik, I. (1996) · Investigative Radiology · doi:10.1097/00004424-199606000-00006 · Cited by 79 · see citing works

Proton Magnetic Resonance Spectroscopy During Initial Treatment With Antipsychotic Medication in Schizophrenia

Bustillo, J., Rowland, L. M., Jung, R. E., Brooks, W. M., Qualls, C., Hammond, R., Hart, B. L., & Lauriello, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301631 · Cited by 73 · see citing works

Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure

Bustillo, J., Lauriello, J., Rowland, L. M., Thomson, L., Petropoulos, H., Hammond, R., HART, B., & Brooks, W. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00210-4 · Cited by 70 · see citing works

Subchronic Phencyclidine Treatment Decreases the Number of Dendritic Spine Synapses in the Rat Prefrontal Cortex

Hajszán, T., Léránth, C., & Roth, R. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.015 · Cited by 68 · see citing works

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia

Fannon, D. G., Simmons, A., Tennakoon, L., O’Ceallaigh, S., Sumich, A. L., Doku, V. C. K., Shew, C., & Sharma, T. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00185-9 · Cited by 64 · see citing works

Metabolic alterations in focally activated primary somatosensory cortex of α-chloralose-anesthetized rats measured by 1H MRS at 11.7 T

Xu, S., Yang, J., Li, C. Q., Zhu, W., & Shen, J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.016 · Cited by 59 · see citing works

Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia [published erratum appears in Am J Psychiatry 1997 Aug;154(8):1180]

Baldessarini, R. J., Hegarty, J. D., Bird, E. D., & Benes, F. M. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.861 · Cited by 57 · see citing works

Brain gray and white matter transverse relaxation time in schizophrenia

Pfefferbaum, A., Sullivan, E. V., Hedehus, M., Moseley, M. E., & Lim, K. O. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00023-2 · Cited by 57 · see citing works

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

Reynolds, L. M., Cochran, S. M., MORRIS, B. J., Pratt, J. A., & Reynolds, G. P. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.003 · Cited by 53 · see citing works

Quantitative Neuropathologic Correlates of Changes in Ratio ofN-acetylaspartate to Creatine in Macaque Brain

Lentz, M. R., Kim, J. P., Westmoreland, S. V., Greco, J. B., Fuller, R. A., Ratai, E., He, J., Sehgal, P. K., Halpern, E. F., Lackner, A. A., et al. (2005) · Radiology · doi:10.1148/radiol.2352040003 · Cited by 53 · see citing works

Long-Term Treatment of Rats with Haloperidol: Lack of an Effect on Brain N-Acetyl Aspartate Levels

Bustillo, J., Barrow, R., Paz, R. D., Tang, J., Seraji‐Bozorgzad, N., Moore, G. J., Bolognani, F., Lauriello, J., Perrone‐Bizzozero, N. I., & Galloway, M. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300874 · Cited by 42 · see citing works

Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels

Bustillo, J., Wolff, C. R., Myers-y-Gutierrez, A., Dettmer, T. S., Cooper, T. B., Allan, A. M., Lauriello, J., & Valenzuela, C. F. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00528-5 · Cited by 26 · see citing works

Radiation Therapy of Hodgkin??s Disease in Children

Connell, H. C., & Evans, J. C. (1971) · Investigative Radiology · doi:10.1097/00004424-197109000-00030 · Cited by 6 · see citing works

Untitled work

Buckley (1999) · doi:10.1002/(sici)1522-2594(199901)41:1

Glutamate and dopamine in schizophrenia: An update for the 21 ^st century

Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702 · see citing works

Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies

Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457 · see citing works

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J., & McGuire, P. K. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0442 · Cited by 367 · see citing works

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

Mao, X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1519 · Cited by 296 · see citing works

MR Spectroscopic Studies of the Brain in Psychiatric Disorders

Maddock, R. J., & Buonocore, M. H. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_197 · Cited by 266 · see citing works

Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis

de la Fuente-Sandoval, C., León-Ortíz, P., Favila, R., Stephano, S., Mamo, D., Ramírez-Bermúdez, J., & Graff-Guerrero, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.65 · Cited by 248 · see citing works

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive

Mouchlianitis, E. D., Bloomfield, M., Law, V., Beck, K., Selvaraj, S., Rasquinha, N., Waldman, A. D., Turkheimer, F., Egerton, A., Stone, J. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv151 · Cited by 226 · see citing works

The neurochemical profile quantified by in vivo 1H NMR spectroscopy

Duarte, J. M. N., Lei, H., Mlynárik, V., & Rolf Gruetter, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.038 · Cited by 222 · see citing works

The neurobiology and treatment of first-episode schizophrenia

Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219 · see citing works

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205 · see citing works

Neurometabolites in schizophrenia and bipolar disorder — A systematic review and meta-analysis

Kraguljac, N. V., Reid, M. A., White, D. M., Jones, R., den Hollander, J., Lowman, D., & Lahti, A. C. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.02.003 · Cited by 204 · see citing works

Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis

de la Fuente‐Sandoval, C., León-Ortíz, P., Azcárraga, M., Stephano, S., Favila, R., Díaz-Galvis, L., Alvarado-Alanis, P., Ramírez‐Bermúdez, J., & Graff‐Guerrero, A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.289 · Cited by 181 · see citing works

Translating Glutamate: From Pathophysiology to Treatment

Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168 · see citing works

Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia

Egerton, A., Brugger, S. P., Raffin, M., Barker, G. J., Lythgoe, D. J., McGuire, P. K., & Stone, J. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.113 · Cited by 168 · see citing works

Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study

Rowland, L. M., Pradhan, S., Korenic, S. A., Wijtenburg, S. A., Hong, L. E., Edden, R. A. E., & Barker, P. B. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.239 · Cited by 160 · see citing works

Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings

Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Javitt, D. C., Lieberman, J. A., Abi‐Dargham, A., & Girgis, R. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.013 · Cited by 158 · see citing works

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies

Nakahara, T., Tsugawa, S., Noda, Y., Ueno, F., Honda, S., Kinjo, M., Segawa, H., Hondo, N., Mori, Y., Watanabe, H., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01297-6 · Cited by 157 · see citing works

In Vivo Measurements of Glutamate, GABA, and NAAG in Schizophrenia

Rowland, L. M., Kontson, K. L., West, J., Edden, R. A. E., Zhu, H., Wijtenburg, S. A., Holcomb, H. H., & Barker, P. B. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs092 · Cited by 150 · see citing works

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level

Merritt, K., McGuire, P. K., Egerton, A., 1H-MRS in Schizophrenia Investigators, Aleman, A., Block, W., Bloemen, O., Borgan, F., Bustillo, J., Capizzano, A. A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0380 · Cited by 142 · see citing works

Updating the mild encephalitis hypothesis of schizophrenia

Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 141 · see citing works

Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)

Egerton, A., Broberg, B. V., van Haren, N. E. M., Merritt, K., Barker, G. J., Lythgoe, D. J., Pérez‐Iglesias, R., Baandrup, L., Düring, S. W., Sendt, K.-V., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0082-9 · Cited by 127 · see citing works

Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia

Höflich, A. S., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Windischberger, C., Saria, A., Kasper, S. F., Winkler, D., & Lanzenberger, R. R. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv040 · Cited by 125 · see citing works

N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development

das Neves Duarte, J. M., Kulak, A., Gholam-Razaee, M. M., Cuenod, M., Gruetter, R., & Do, K. Q. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.035 · Cited by 124 · see citing works

Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124 · see citing works

Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in Schizophrenia

Reid, M. A., Stoeckel, L. E., White, D. M., Avsar, K. B., Bolding, M., Akella, N. S., Knowlton, R. C., den Hollander, J. A., & Lahti, A. C. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.013 · Cited by 122 · see citing works

Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy

Duarte, J. M. N., Kim, Q., & Rolf Gruetter, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.135 · Cited by 108 · see citing works

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia

McIlwain, M., Anderson, V. M., Pillai, A., Kydd, R. R., & Russell, B. R. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu117 · Cited by 104 · see citing works

Towards a theory of functional magnetic resonance spectroscopy ( fMRS ): A meta‐analysis and discussion of using MRS to measure changes in neurotransmitters in real time

Mullins, P. G. (2018) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12411 · Cited by 101 · see citing works

Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia

Natsubori, T., Inoue, H., Abe, O., Takano, Y., Iwashiro, N., Aoki, Y. Y., Koike, S., Yahata, N., Katsura, M., Gonoi, W., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt124 · Cited by 100 · see citing works

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis

Merritt, K., McGuire, P. K., & Egerton, A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00151 · Cited by 100 · see citing works

Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla

Bustillo, J., Chen, H., Gasparovic, C., Mullins, P. G., Caprihan, A., Qualls, C., Apfeldorf, W. J., Lauriello, J., & Posse, S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.024 · Cited by 94 · see citing works

Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia

Rowland, L. M., Summerfelt, A. T., Wijtenburg, S. A., Du, X. M., Chiappelli, J., Krishna, N., West, J., Muellerklein, F., Kochunov, P. V., & Hong, L. E. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2680 · Cited by 96 · see citing works

Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy

de la Fuente‐Sandoval, C., Reyes-Madrigal, F., Mao, X., León-Ortíz, P., Rodríguez-Mayoral, O., Solís‐Vivanco, R., Favila, R., Graff‐Guerrero, A., & Shungu, D. C. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv105 · Cited by 88 · see citing works

Relationship Between Brain Glutamate Levels and Clinical Outcome in Individuals at Ultra High Risk of Psychosis

Egerton, A., Stone, J. M., Chaddock, C. A., Barker, G. J., Bonoldi, I., Howard, R. M., Merritt, K., Allen, P., Howes, O. D., Murray, R. M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.143 · Cited by 85 · see citing works

Electroencephalographic Spectral and Coherence Analysis of Ketamine in Rats: Correlation with Behavioral Effects and Pharmacokinetics

Páleníček, T., Fujáková, M., Brunovský, M., Balı́ková, M., Horáček, J., Gorman, I., Tylš, F., Tislerova, B., Šóš, P., Bubeníková‐Valešová, V., et al. (2011) · Neuropsychobiology · doi:10.1159/000321803 · Cited by 85 · see citing works

Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia

Kraguljac, N. V., Reid, M. A., White, D. M., den Hollander, J., & Lahti, A. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.126 · Cited by 84 · see citing works

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies

Egerton, A., Bhachu, A., Merritt, K., McQueen, G., Szulc, A., & McGuire, P. K. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00066 · Cited by 84 · see citing works

7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings

Thakkar, K. N., Rösler, L., Wijnen, J. P., Boer, V. O., Klomp, D. W. J., Cahn, W., Kahn, R. S., & Neggers, S. F. W. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.007 · Cited by 82 · see citing works

N-Acetylaspartylglutamate (NAAG) and N-Acetylaspartate (NAA) in Patients With Schizophrenia

Jessen, F., Fingerhut, N., Sprinkart, A. M., Kühn, K.-U., Petrovsky, N., Maier, W., Schild, H. H., Block, W., Wagner, M., & Träber, F. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr127 · Cited by 82 · see citing works

In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: Application to schizophrenia

Wijtenburg, S. A., Yang, S., Fischer, B. A., & Rowland, L. M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.007 · Cited by 78 · see citing works

Neural substrates underlying effort computation in schizophrenia.

Fervaha, G., Foussias, G., Agid, O., & Remington, G. (2013) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.001 · Cited by 79 · see citing works

Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis

Merritt, K., McCutcheon, R. A., Aleman, A., Ashley, S. A., Beck, K., Block, W., Bloemen, O., Borgan, F., Boules, C., Bustillo, J., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01991-7 · Cited by 82 · see citing works

Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients

de la Fuente‐Sandoval, C., Reyes-Madrigal, F., Mao, X., León-Ortíz, P., Rodríguez-Mayoral, O., Jung-Cook, H. H., Solís‐Vivanco, R., Graff‐Guerrero, A., & Shungu, D. C. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.09.028 · Cited by 73 · see citing works

Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: A phantom study at 4 Tesla

Henry, M., Lauriat, T. L., Shanahan, M. E., Renshaw, P. F., & Jensen, J. E. (2010) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2010.11.003 · Cited by 73 · see citing works

Neurochemical changes in patients with chronic low back pain detected by proton magnetic resonance spectroscopy: A systematic review

Zhao, X., Xu, M., Jorgenson, K., & Kong, J. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.11.006 · Cited by 75 · see citing works

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

Bojesen, K. B., Ebdrup, B. H., Jessen, K., Sigvard, A. K., Tangmose, K., Edden, R. A. E., Larsson, H. B. W., Rostrup, E., Broberg, B. V., & Glenthoj, B. Y. (2019) · Psychological Medicine · doi:10.1017/s0033291719002277 · Cited by 72 · see citing works

Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A 1H MRS Study at 7Tesla

Brandt, A. S., Unschuld, P. G., Pradhan, S., Lim, I. A. L., Churchill, G., Harris, A. D., Hua, J., Barker, P. B., Ross, C. A., van Zijl, P. C. M., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.017 · Cited by 70 · see citing works

Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation.

Salavati, B., Rajji, T., Price, R., Sun, Y.-M., Graff-Guerrero, A., & Daskalakis, Z. (2015) · Schizophrenia bulletin · doi:10.1093/schbul/sbu132 · Cited by 66 · see citing works

N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: A systematic review

Paslakis, G., Träber, F., Roberz, J., Block, W., & Jessen, F. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.004 · Cited by 69 · see citing works

Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism

Duarte, J. M. N., & Xin, L. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2521-z · Cited by 69 · see citing works

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis

Bojesen, K. B., Broberg, B. V., Fagerlund, B., Jessen, K., Thomas, M. B., Sigvard, A. K., Tangmose, K., Nielsen, M. Ø., Andersen, G. S., Larsson, H. B. W., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.027 · Cited by 68 · see citing works

Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies

Schwerk, A. M. K., Alves, F. D. S., Pouwels, P. J. W., & van Amelsvoort, T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12398 · Cited by 68 · see citing works

Electrophysiological evidence for abnormal glutamate-GABA association following psychosis onset

Koshiyama, D., Kirihara, K., Tada, M., Nagai, T., Fujioka, M., Ichikawa, E., Ohta, K., Tani, M., Tsuchiya, M., Kanehara, A., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0261-0 · Cited by 66 · see citing works

Venlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the Brain

Zhang, Y., Bi, X., Adebiyi, O. A., Wang, J., Mooshekhian, A., Cohen, J., Wei, Z., Wang, F., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00332 · Cited by 63 · see citing works

In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study

Chiu, P. W., Lui, S. S. Y., Hung, K. S. Y., Chan, R. C. K., Chan, Q., Sham, P. C., Cheung, E. F. C., & Mak, H. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.021 · Cited by 60 · see citing works

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia

Yoshimura, R., Gotō, N., Kakeda, S., Nishimura, J., Moriya, J., Hayashi, K., Hori, H., Ikenouchi, A., Umen-Nakano, W., Katsuki, A., et al. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s25582 · Cited by 58 · see citing works

Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample

Bustillo, J., Jones, T., Chen, H., Lemke, N. T., Abbott, C., Qualls, C., Stromberg, S. F., Cañive, J. M., & Gasparovic, C. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw122 · Cited by 58 · see citing works

Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System

Gruber, O., Chadha, A. S., & Aach, H. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00032 · Cited by 54 · see citing works

Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis

Whitehurst, T., Osugo, M., Townsend, L., Shatalina, E., Vava, R., Onwordi, E. C., & Howes, O. D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.001 · Cited by 53 · see citing works

Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders

Xu, H., Zhang, H., Zhang, J., Huang, Q., Shen, Z., & Wu, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.027 · Cited by 51 · see citing works

Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

Smucny, J., Carter, C. S., & Maddock, R. J. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.06.008 · Cited by 50 · see citing works

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Egerton, A., & Stone, J. M. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800784961 · Cited by 49 · see citing works

Exploring intermediate phenotypes with EEG: Working memory dysfunction in schizophrenia

Haenschel, C., & Linden, D. E. J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.045 · Cited by 47 · see citing works

Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study

Wijtenburg, S. A., Wright, S. N., Korenic, S. A., Gaston, F. E., Ndubuizu, N., Chiappelli, J., McMahon, R. P., Chen, H., Savransky, A., Du, X. M., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.172 · Cited by 47 · see citing works

The influence of the glutamatergic system on cognition in schizophrenia: A systematic review

Thomas, E. H. X., Bozaoglu, K., Rossell, S. L., & Gurvich, C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.005 · Cited by 47 · see citing works

In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time–Averaged Proton Magnetic Resonance Spectroscopy at 4T

Kim, S.-Y., Kaufman, M. J., Cohen, B. M., Jensen, J. E., Coyle, J. T., Du, F., & Öngür, D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.022 · Cited by 47 · see citing works

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)

Kinon, B. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00757 · Cited by 47 · see citing works

Ketamine-dependent neuronal activation in healthy volunteers

Höflich, A. S., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Ganger, S., Spies, M., Windischberger, C., Kasper, S. F., Winkler, D., et al. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1291-0 · Cited by 45 · see citing works

A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia

Reid, M. A., White, D. M., Kraguljac, N. V., & Lahti, A. C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.12.003 · Cited by 43 · see citing works

Comparison of reproducibility of single voxel spectroscopy and whole‐brain magnetic resonance spectroscopy imaging at 3T

Zhang, Y., Taub, E., Salibi, N., Uswatte, G., Maudsley, A. A., Sheriff, S., Womble, B., Mark, V. W., & Knight, D. C. (2018) · NMR in Biomedicine · doi:10.1002/nbm.3898 · Cited by 43 · see citing works

Marine omega-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD

Dervola, K.-S. N., Roberg, B., Wøien, G., Bogen, I. L., Sandvik, T., Sagvolden, T., Drevon, C. A., Johansen, E. B., & Walaas, S. I. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-56 · Cited by 42 · see citing works

Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia

Gallinat, J., McMahon, K., Kühn, S., Schubert, F., & Schaefer, M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv124 · Cited by 42 · see citing works

Metabolite Alterations in Adults With Schizophrenia, First Degree Relatives, and Healthy Controls: A Multi-Region 7T MRS Study

Wijtenburg, S. A., Wang, M., Korenic, S. A., Chen, S., Barker, P. B., & Rowland, L. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.656459 · Cited by 41 · see citing works

A mean-field model of glutamate and GABA synaptic dynamics for functional MRS

Lea‐Carnall, C., El‐Deredy, W., Stagg, C. J., Williams, S. R., & Trujillo‐Barreto, N. J. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119813 · Cited by 40 · see citing works

Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders

Hermens, D. F., Lagopoulos, J., Naismith, S. L., Tobias‐Webb, J., & Hickie, I. B. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.35 · Cited by 40 · see citing works

Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies

Kubota, M., Moriguchi, S., Takahata, K., Nakajima, S., & Horita, N. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.069 · Cited by 38 · see citing works

Magnetic Resonance Spectroscopy Studies of Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic Psychosis

Stein, A., Zhu, C., Du, F., & Öngür, D. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01457-1 · Cited by 36 · see citing works

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate

Merritt, K., Pérez‐Iglesias, R., Sendt, K.-V., Arvanitis, A., Jauhar, S., Pepper, F., Barker, G. J., Glenthoj, B. Y., Arango, C., Lewis, S. W., et al. (2019) · Schizophrenia · doi:10.1038/s41537-019-0080-1 · Cited by 36 · see citing works

A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia

Cadena, E. J., White, D. M., Kraguljac, N. V., Reid, M. A., Maximo, J. O., Nelson, E. A., Gawronski, B. A., & Lahti, A. C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00632 · Cited by 35 · see citing works

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls

Batalla, A., Bargalló, N., Gassó, P., Molina-Andreu, O., Pareto, D., Mas, S., de la Roca, J. M., Bernardo, M., Lafuente, A., & Parellada, E. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.122 · Cited by 34 · see citing works

Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms

Harnett, N. G., Wood, K. H., Ference, E. W., Reid, M. A., Lahti, A. C., Knight, A. J., & Knight, D. C. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.04.010 · Cited by 31 · see citing works

Serum copper and zinc levels correlate with biochemical metabolite ratios in the prefrontal cortex and lentiform nucleus of patients with major depressive disorder

Liu, X., Zhong, S., Li, Z., Chen, J., Wang, Y., Lai, S., Miao, H., & Jia, Y. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109828 · Cited by 32 · see citing works

Progressive Changes in Glutamate Concentration in Early Stages of Schizophrenia: A Longitudinal 7-Tesla MRS Study

Jeon, P., Limongi, R., Ford, S. D., Mackinley, M., Dempster, K., Théberge, J., & Palaniyappan, L. K. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa072 · Cited by 32 · see citing works

Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: A 1H MRS study at 3Tesla

Crocker, C. E., Bernier, D. C., Hanstock, C. C., Lakusta, B., Purdon, S. E., Seres, P., & Tibbo, P. G. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.004 · Cited by 32 · see citing works

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

Bojesen, K. B., Andersen, K. A., Rasmussen, S. N., Baandrup, L., Madsen, L. M., Glenthoj, B. Y., Rostrup, E., & Broberg, B. V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00022 · Cited by 31 · see citing works

In Vivo Neurometabolic Profiling to Characterize the Effects of Social Isolation and Ketamine-Induced NMDA Antagonism: A Rodent Study at 7.0 T

Napolitano, A., Shah, K., Schubert, M. I., Porkess, V., Fone, K. C. F., & Auer, D. P. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt067 · Cited by 31 · see citing works

The potential of 1H-MRS in CNS drug development

Egerton, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05344-7 · Cited by 30 · see citing works

Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study

Legind, C. S., Broberg, B. V., Mandl, R. C. W., Brouwer, R. M., Anhøj, S. J., Hilker, R. W., Jensen, M. H., McGuire, P. K., Pol, H. E. H., Fagerlund, B., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0236-0 · Cited by 29 · see citing works

Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation

Ota, M., Ishikawa, M., Sato, N., Hori, H., Sasayama, D., Hattori, K., Teraishi, T., Nakata, Y., & Kunugi, H. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01853.x · Cited by 29 · see citing works

Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence

Treen, D., Vila, S., Mollà, L., Forcadell, E., Chamorro, J., Bulbena, A., & Pérez, V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.005 · Cited by 27 · see citing works

Reduced N-acetylaspartate in the hippocampus in patients with fibromyalgia: A meta-analysis

Aoki, Y. Y., Inokuchi, R., & Suwa, H. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.03.008 · Cited by 26 · see citing works

Altered 13 C Glucose Metabolism in the Cortico—Striato—Thalamo—Cortical Loop in the MK-801 Rat Model of Schizophrenia

Eyjolfsson, E. M., Nilsen, L. H., Kondziella, D., Brenner, E., Haberg, A. K., & Sonnewald, U. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.193 · Cited by 25 · see citing works

Relationship Between Genetic Variation in the Glutaminase Gene GLS1 and Brain Glutamine/Glutamate Ratio Measured In Vivo

Öngür, D., Haddad, S. A., Prescot, A. P., Jensen, J. E., Siburian, R., Cohen, B. M., Renshaw, P. F., & Smoller, J. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.033 · Cited by 26 · see citing works

White matter tract abnormalities in first-episode psychosis

Lee, D. Y., Smith, G. N., Su, W., Honer, W. G., MacEwan, G. W., Lapointe, J. S., Vertinsky, A. T., Vila‐Rodriguez, F., Kopala, L. C., & Lang, D. J. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.042 · Cited by 26 · see citing works

Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status

Yang, Y. S., Smucny, J., Zhang, H., & Maddock, R. J. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103461 · Cited by 24 · see citing works

Age-related change of neurochemical abnormality in attention-deficit hyperactivity disorder: A meta-analysis

Aoki, Y. Y., Inokuchi, R., Suwa, H., & Aoki, A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.019 · Cited by 26 · see citing works

Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis

Kirov, I. I., & Tal, A. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27912 · Cited by 23 · see citing works

Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis

Sonnenschein, S. F., & Grace, A. A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1849144 · Cited by 23 · see citing works

N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients

Zong, X., Hu, M., Li, Z., Cao, H., Hé, Y., Liao, Y., Zhou, J., Sang, D., Zhao, H., Tang, J., et al. (2015) · Scientific Reports · doi:10.1038/srep09109 · Cited by 22 · see citing works

Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia

Reid, M., Kraguljac, N., Avsar, K. B., White, D., den Hollander, J., & Lahti, A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.036 · Cited by 25 · see citing works

7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia

Reid, M. A., Salibi, N., White, D. M., Gawne, T. J., Denney, T. S., & Lahti, A. C. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx190 · Cited by 106 · see citing works

Glutamatergic hypo-function in the left superior and middle temporal gyri in early schizophrenia: a data-driven three-dimensional proton spectroscopic imaging study

Bustillo, J., Upston, J., Mayer, E. G., Jones, T., Maudsley, A. A., Gasparovic, C., Tohen, M. F., & Lenroot, R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0707-y · Cited by 12 · see citing works

O6.8. GLUTAMATERGIC DYSFUCTION AND TREATMENT RESPONSE IN MINIMALLY TREATED AND CHRONIC SCHIZOPHRENIA PATIENTS

Mouchlianitis, E. D., Vanes, L. D., Barry, E. F., Patel, K., Wong, K., Porffy, L., & Shergill, S. S. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby015.229

Glutamate and Glutamine Measured With 4.0 T Proton MRS in Never-Treated Patients With Schizophrenia and Healthy Volunteers

Théberge, J., Bartha, R., Drost, D. J., Menon, R. S., MALLA, A. K., Takhar, J., Neufeld, R. W. J., Rogers, J. S., Pavlosky, W. F., Schaefer, B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1944 · Cited by 398 · see citing works

Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia

Natsubori, T., Inoue, H., Abe, O., Takano, Y., Iwashiro, N., Aoki, Y. Y., Koike, S., Yahata, N., Katsura, M., Gonoi, W., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt124 · Cited by 100 · see citing works